Clinical Trial Update: Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cognitive-behavioral therapy for patients with mild Alzheimer's disease and their caregivers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University of Zurich | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED